Physician profile
Jeremy A Weingarten
NPI 1316134489
$1,415.27
in general payments reported to CMS, 2019-2025
8 companies · $1,180 in 2025
The $1,180 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.52 · 2021: $20.31 · 2023: $18.45 · 2024: $99.99 · 2025: $1,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $757 · Food and Beverage: $441 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $757.28 |
| Food and Beverage | $441.17 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $984.34 | 2025 | Inspire |
| Itamar Medical INC | $195.66 | 2025 | Watchpatone |
| Actelion Pharmaceuticals US, INC. | $99.99 | 2024 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $49.38 | 2019 | |
| Glaxosmithkline, LLC. | $23.61 | 2019 | |
| Insmed, INC. | $23.53 | 2019 | |
| La Jolla Pharmaceutical Company | $20.31 | 2021 | |
| Coaptech, INC. | $18.45 | 2023 | Puma System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Weingarten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.